alexa Immunotherapy Targeting Cancer Stem Cells of Human Colorectal Cancer | OMICS International | Abstract
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Immunotherapy Targeting Cancer Stem Cells of Human Colorectal Cancer

Tadashi Ogawa1,2, Yoshihiko Hirohashi1*, Toshihiko Torigoe1, Noriyuki Sato1 and Koichi Hirata2

1Department of Pathology, Sapporo Medical University School of Medicine, South-1 West-17, Chuo-ku, Sapporo 060-8556, Japan

2Department of Surgery, Sapporo Medical University School of Medicine, South-1 West-17, Chuo-ku, Sapporo 060-8556, Japan

*Corresponding Author:
Yoshihiko Hirohashi
Department of Pathology
Sapporo Medical University School of Medicine
South-1 West-17, Chuo-ku
Sapporo 060-8556, Japan
E-mail: [email protected]

Received date: April 20, 2013; Accepted date: June 04, 2013; Published date: June 06, 2013

Citation: Ogawa T, Hirohashi Y, Torigoe T, Sato N, Hirata K (2013) Immunotherapy Targeting Cancer Stem Cells of Human Colorectal Cancer. J Gastroint Dig Syst S12:014. doi:10.4172/2161-069X.S12-014

Copyright: © 2013 Ogawa T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Colorectal cancer is one of the most common malignancies worldwide. Despite improvements in surgical therapy and chemotherapy, the overall survival rate of patients with recurrence or metastatic cancer has not improved significantly in the past several decades. Treatment resistance makes the disease incontrollable, and recent basic research has revealed that cancer stem-like cells (CSCs) or cancer-initiating cells (CICs) are involved in treatment resistance. Therefore, eradicating CSCs/CICs is a key approach to improve colorectal cancer treatment. Cancer immunotherapy is expected to become the fourth cancer treatment option, and several studies have shown that CSCs/CICs can be targeted by immunotherapy. In this review article, we summarize the potency of immunotherapy as CSC/CIC-targeting therapy and the future perspectives of CSC/CIC-targeting immunotherapy.

Keywords

Recommended Conferences
Share This Page
Top